Posterior Reversible Encephalopathy Syndrome Following Chemotherapy and Immune Checkpoint Inhibitor Combination in a Patient with Small-Cell Lung Cancer

被引:3
|
作者
Evin, Cecile [1 ]
Lassau, Nathalie [1 ,2 ]
Balleyguier, Corinne [1 ,2 ]
Assi, Tarek [3 ]
Ammari, Samy [1 ,2 ]
机构
[1] Univ Paris Saclay, Dept Imaging, Gustave Roussy, F-94805 Villejuif, France
[2] Univ Paris Saclay, CNRS, Biomaps, INSERM,CEA,UMR1281, F-94805 Villejuif, France
[3] Univ Paris Saclay, Dept Oncol, Gustave Roussy, F-94805 Villejuif, France
关键词
PRES; chemotherapy; immunotherapy; status epilepticus; diaschisis; LEUKOENCEPHALOPATHY SYNDROME; CARBOPLATIN; IMMUNOTHERAPY;
D O I
10.3390/diagnostics12061369
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Posterior reversible encephalopathy syndrome (PRES) is a rare neurological complication that occurs following a sudden blood pressure increase. We report the case of a 64-year-old patient presenting PRES several hours after the administration of a combination of chemotherapy and a checkpoint inhibitor (carboplatin-etoposide-atezolizumab) for small-cell lung cancer. He presented consciousness disorders associated with partial epileptic seizure secondarily generalized. His arterial blood pressure was elevated and brain imaging showed multiple bilateral subcortical parietal, temporal, occipital and cerebellar T2 high signals, predominantly in the posterior region. There were no abnormal T1 signals nor bleeding but a left apparent diffusion coefficient restriction was noted. On arterial spin labelling perfusion sequences, there was an increased perfusion within the left temporo-parieto-occipital, left thalamic and right cerebellar regions. Finally, the neurological symptoms completely regressed after several days of optimal antihypertensive and antiepileptic treatment. The clinical context and radiological features, as well as the progressive resolution of the neurological symptoms, were all in favor of PRES. PRES can occur after the administration of chemotherapy and/or immunotherapy. Prompt diagnosis is crucial through a spectrum of suspicious clinical and radiological characteristics that must be rapidly recognized to quickly anticipate the optimal therapeutic strategy and avoid unnecessary complications.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Increased risk of Lambert-Eaton myasthenic syndrome (LEMS) in small-cell lung cancer patients treated with immune checkpoint inhibitor
    Imai, Shungo
    Mitsuboshi, Satoru
    Hori, Satoko
    Suzuki, Shigeaki
    EUROPEAN JOURNAL OF CANCER, 2023, 180 : 1 - 3
  • [22] Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer
    Liu, Wei
    Zhang, Lei
    Xiu, Zhiming
    Guo, Jian
    Wang, Liye
    Zhou, Yue
    Jiao, Yang
    Sun, Meiyan
    Cai, Jianhui
    ONCOTARGETS AND THERAPY, 2020, 13 : 7229 - 7241
  • [23] A Timeline of Immune Checkpoint Inhibitor Aporovals in Small Cell Lung Cancer
    Gill, Jennifer
    Cetnar, Jeremy Paul
    Prasad, Vinay
    TRENDS IN CANCER, 2020, 6 (09): : 736 - 738
  • [24] Theory Meets Practice for Immune Checkpoint Blockade in Small-Cell Lung Cancer
    Riess, Jonathan W.
    Lara, Primo N., Jr.
    Gandara, David R.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (31) : 3717 - +
  • [25] Small-cell Lung Carcinoma with Gastrointestinal Pseudo-obstruction as a Paraneoplastic Neurological Syndrome Elicited by an Immune Checkpoint Inhibitor
    Saitou, Atsushi
    Shioya, Makoto
    Nagahisa, Yuta
    Haseyama, Aoi
    Niwa, Rumi
    Tsuchimoto, Jyuri
    Chiba, Hirofumi
    INTERNAL MEDICINE, 2024, 63 (14) : 2059 - 2062
  • [26] Recurrent Posterior Reversible Encephalopathy Syndrome in a Sickle Cell Patient
    Nair, Anjana
    Testai, Fernando D.
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2011, 103 (02) : 170 - 172
  • [27] COMBINATION CHEMOTHERAPY AND RADIOTHERAPY IN SMALL-CELL CARCINOMA OF LUNG
    KING, GA
    COMIS, R
    GINSBERG, S
    GOLDBERG, J
    DALE, HT
    BROWN, J
    DALAL, P
    CHUNG, C
    GOTTLIEB, A
    RADIOLOGY, 1977, 125 (02) : 529 - 530
  • [28] Combined immune checkpoint inhibitor and chemotherapy is effective in a patient with ALK rearranged non-small cell lung cancer: a case report
    Xia, Lexin
    Hu, Hanguang
    Li, Wen
    Shen, Huahao
    Xia, Yang
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (03) : 2045 - 2048
  • [29] Posterior reversible encephalopathy syndrome in a patient following binge liquorice ingestion
    Morgan, Robert David
    Chou, Sophia H.
    Stelfox, Henry Thomas
    JOURNAL OF NEUROLOGY, 2011, 258 (09) : 1720 - 1722
  • [30] Posterior reversible encephalopathy syndrome in a patient following binge liquorice ingestion
    Robert David Morgan
    Sophia H. Chou
    Henry Thomas Stelfox
    Journal of Neurology, 2011, 258 : 1720 - 1722